PRINCETON, N.J., Oct. 24 /PRNewswire-FirstCall/ -- Orchid Cellmark Inc. (Nasdaq: ORCH), a leading worldwide provider of identity DNA testing services, will release its third quarter 2008 financial results on Thursday, October 30, 2008 at approximately 7:00 a.m. EDT, and is hosting a conference call and webcast to discuss the results at 10:00 a.m. EDT on the same day. Management will discuss financial results for the third quarter 2008 as well as operating highlights. A question-and-answer session will follow management's discussion. All interested parties are encouraged to listen to the live conference call or the live or archived webcast.

    Conference Call Details

    Date and Time:    Thursday, October 30, 2008 at 10:00 a.m. EDT

    Dial-In:          US/Canada:        (877) 266-0703
                      Int'l/Local:      (706) 643-7682
                      Conference ID:     70588526

    Webcast:  Live webcast and replay available via the Investor Relations section of the company's website at www.orchidcellmark.com.  The webcast will be available for 90 days.

About Orchid Cellmark

Orchid Cellmark (Nasdaq: ORCH) is a leading international provider of DNA testing services primarily for forensic and family relationship applications. Orchid Cellmark is one of the largest providers of forensic DNA testing services and its DNA results are used by the criminal justice system to assist with the identification of perpetrators, the exclusion of suspects and the exoneration of wrongfully convicted individuals. The company provides DNA family relationship testing to numerous child services organizations and individuals seeking to verify parentage. Orchid Cellmark also serves immigration and security authorities for DNA testing of individuals. In the agriculture field, the company provides DNA testing services for selective trait breeding. Orchid Cellmark's strong market positions in these areas reflect the company's accredited laboratories in the U.S. and U.K., its innovative genetic analysis technologies and expertise, and the company's reputation for exceptional quality, reliability and customer service for nearly two decades. More information on Orchid Cellmark can be found at www.orchidcellmark.com.

    Contact:
    Investors:                  Media:
    Mary Bashore                Rick Anderson
    Orchid Cellmark Inc.        The Torrenzano Group
    (609) 750-2324              (212) 681-1700
    ir@orchid.com               randerson@torrenzano.com

SOURCE Orchid Cellmark Inc.